High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 Study.
cancer subtypes
gastric adenocarcinoma
gastric cancer
molecular
prognosis
survival
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
30 Aug 2019
30 Aug 2019
Historique:
received:
02
08
2019
revised:
21
08
2019
accepted:
28
08
2019
entrez:
5
9
2019
pubmed:
5
9
2019
medline:
5
9
2019
Statut:
epublish
Résumé
Gastric cancer (GC) is a heterogeneous disease. This heterogeneity applies not only to morphological and phenotypic features but also to geographical variations in incidence and mortality rates. As Chile has one of the highest mortality rates within South America, we sought to define a molecular profile of Chilean GCs (ClinicalTrials.gov identifier: NCT03158571/(FORCE1)). Solid tumor samples and clinical data were obtained from 224 patients, with subsets analyzed by tissue microarray (TMA;
Identifiants
pubmed: 31480291
pii: cancers11091275
doi: 10.3390/cancers11091275
pmc: PMC6770659
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT03158571']
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fondo Nacional de Desarrollo Científico y Tecnológico
ID : 1180173
Organisme : Fondo Nacional de Desarrollo Científico y Tecnológico
ID : 1180241
Organisme : Fondo Nacional de Desarrollo Científico y Tecnológico
ID : 1191928
Organisme : National Natural Science Foundation of China
ID : 81472637
Organisme : National Natural Science Foundation of China
ID : 81672784
Organisme : National Natural Science Foundation of China
ID : 81872655
Organisme : Comisión Nacional de Investigación Científica y Tecnológica
ID : 21150695
Références
Gastroenterology. 2011 Aug;141(2):476-85, 485.e1-11
pubmed: 21684283
Nat Med. 2015 May;21(5):449-56
pubmed: 25894828
Clin Cancer Res. 2010 Jun 15;16(12):3253-9
pubmed: 20530692
BMC Cancer. 2015 Oct 24;15:782
pubmed: 26498209
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28890946
J Transl Med. 2012 Jul 09;10:85
pubmed: 22554099
Cancers (Basel). 2019 Feb 14;11(2):null
pubmed: 30769835
Scand J Gastroenterol. 2018 Feb;53(2):124-129
pubmed: 29275643
Medicine (Baltimore). 2018 Apr;97(16):e0419
pubmed: 29668600
Nature. 2014 Sep 11;513(7517):202-9
pubmed: 25079317
Nature. 2015 Oct 22;526(7574):583-6
pubmed: 26466569
Nat Genet. 2014 Jun;46(6):583-7
pubmed: 24816255
Nat Med. 2018 Sep;24(9):1449-1458
pubmed: 30013197
Int J Cancer. 2012 Apr 1;130(7):1567-76
pubmed: 21557216
Biomedicines. 2018 Mar 09;6(1):null
pubmed: 29522457
N Engl J Med. 2015 Aug 20;373(8):726-36
pubmed: 26287849
Mol Cancer Ther. 2015 Apr;14(4):847-56
pubmed: 25695955
Br J Cancer. 2017 Dec 5;117(12):1753-1760
pubmed: 29073638
Oncology. 2007;72(1-2):64-8
pubmed: 18004078
Cell. 2018 Aug 9;174(4):1034-1035
pubmed: 30096302
Clin Cancer Res. 2011 May 1;17(9):2693-701
pubmed: 21430069
Genome Med. 2017 Oct 31;9(1):93
pubmed: 29089060
Gut. 2014 Feb;63(2):236-43
pubmed: 23580779
Gastric Cancer. 2017 Jan;20(1):156-163
pubmed: 26796888
J Gastric Cancer. 2016 Mar;16(1):1-7
pubmed: 27104020
J Cancer. 2018 Jun 6;9(13):2302-2307
pubmed: 30026825
Ecancermedicalscience. 2016 Dec 21;10:707
pubmed: 28105078
J Epidemiol. 2017 Mar;27(3S):S29-S35
pubmed: 28190659
World J Exp Med. 2015 May 20;5(2):84-102
pubmed: 25992323
Biol Res. 2015 Jan 26;48:10
pubmed: 25761441
PLoS One. 2012;7(3):e33421
pubmed: 22457761
Oncotarget. 2017 Jun 15;8(43):75687-75698
pubmed: 29088902
Mod Pathol. 2012 May;25(5):637-50
pubmed: 22222640
Oncotarget. 2016 Jul 5;7(27):42252-60
pubmed: 27323394
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Nat Genet. 2014 Jun;46(6):573-82
pubmed: 24816253
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):662-7
pubmed: 17416755
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Hum Mutat. 2003 Mar;21(3):258-70
pubmed: 12619111
World J Gastroenterol. 2003 May;9(5):905-9
pubmed: 12717828
Int J Cancer. 2001 Nov;94(4):527-30
pubmed: 11745439
J Immunother Cancer. 2019 Jan 31;7(1):24
pubmed: 30704511
Mol Cancer. 2017 Jun 28;16(1):112
pubmed: 28659148
Mol Cancer Ther. 2017 Nov;16(11):2598-2608
pubmed: 28835386
Nat Genet. 2019 Feb;51(2):202-206
pubmed: 30643254
Lancet. 2016 Nov 26;388(10060):2606
pubmed: 27894662
Biol Res. 2008;41(3):303-15
pubmed: 19399343
Biomed Res. 2018;39(3):159-167
pubmed: 29899191